KRAS G12C inhibitor 33
KRAS G12C inhibitor 33 is a selective small molecule compound designed to target the oncogenic KRAS G12C mutation. It is a valuable research tool for investigating targeted cancer therapies, supporting both in vitro cellular studies and in vivo preclinical models of KRAS-driven cancers.
Product Specifications
CAS Number
2648985-02-6
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
O=C1C=2C (=C (N=C (OC[C@H]3N (C) CCC3) N2) N4CCN (C (C=C) =O) CC4) N=C (C) N1C=5C6=C (C=CC5) C=CC=C6
Molecular Formula
C30H33N7O3
Molecular Weight
539.63
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940965-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400977-500 1x 500 µL
TGF-beta (1D11.16.8), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881231-500 1x 500 µL
Eosinophil Peroxidase (AHE-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 